Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Plos One
|
May 22, 2008
Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer
Yanan Yang, Kentaro Iwanaga, Maria Gabriela Raso, et al.
Structure (London, England : 1993)
|
April 20, 2021
Structural basis for the association of PLEKHA7 with membrane-embedded phosphatidylinositol lipids
Alexander E Aleshin, Yong Yao, Amer Iftikhar, et al.
Bioorganic & Medicinal Chemistry
|
July 18, 2013
Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [(131)I] analogue as useful PET tracers for PI3-kinase
Duoli Sun, Basvoju A Bhanu Prasad, Paul T Schuber, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
David L Schwartz, Garth Powis, Arun Thitai-Kumar, et al.
Oncotarget
|
November 3, 2016
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
Hae Ryung Chang, Seungyoon Nam, Jinhyuk Lee, et al.
Cancer Research
|
May 2, 2013
Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer
Taly R Spivak-Kroizman, Galen Hostetter, Richard Posner, et al.
Cancer Research
|
June 5, 2016
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
Geoffrey Grandjean, Petrus R de Jong, Brian James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Scott Kopetz, Jayesh Desai, Emily Chan, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Discovery of a novel class of AKT pleckstrin homology domain inhibitors
Daruka Mahadevan, Garth Powis, Eugene A Mash, et al.
Molecular Cancer Therapeutics
|
March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor
Emmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Plos One
|
May 22, 2008
Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer
Yanan Yang, Kentaro Iwanaga, Maria Gabriela Raso, et al.
Structure (London, England : 1993)
|
April 20, 2021
Structural basis for the association of PLEKHA7 with membrane-embedded phosphatidylinositol lipids
Alexander E Aleshin, Yong Yao, Amer Iftikhar, et al.
Bioorganic & Medicinal Chemistry
|
July 18, 2013
Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [(131)I] analogue as useful PET tracers for PI3-kinase
Duoli Sun, Basvoju A Bhanu Prasad, Paul T Schuber, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects
David L Schwartz, Garth Powis, Arun Thitai-Kumar, et al.
Oncotarget
|
November 3, 2016
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
Hae Ryung Chang, Seungyoon Nam, Jinhyuk Lee, et al.
Cancer Research
|
May 2, 2013
Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer
Taly R Spivak-Kroizman, Galen Hostetter, Richard Posner, et al.
Cancer Research
|
June 5, 2016
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
Geoffrey Grandjean, Petrus R de Jong, Brian James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
Scott Kopetz, Jayesh Desai, Emily Chan, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Discovery of a novel class of AKT pleckstrin homology domain inhibitors
Daruka Mahadevan, Garth Powis, Eugene A Mash, et al.
Molecular Cancer Therapeutics
|
March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor
Emmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Page
of 10